We evaluated the outcome of primary total hip replacement (THR) in 3290 patients with the primary diagnosis of osteoarthritis at a minimum follow-up of two years. They were stratified into categories of body mass index (BMI) based on the World Health Organisation classification of obesity. Statistical analysis was carried out to determine if there was a difference in the post-operative Western Ontario and McMaster Universities osteoarthritis index, the Harris hip score and the Short-Form-12 outcome based on the BMI.

While the pre- and post-operative scores were lower for the group classified as morbidly obese, the overall change in outcome scores suggested an equal if not greater improvement compared with the non-morbidly obese patients. The overall survivorship and rate of complications were similar in the BMI groups although there was a slightly higher rate of revision for sepsis in the morbidly obese group.

Morbid obesity does not affect the post-operative outcome after THR, with the possible exception of a marginally increased rate of infection. Therefore withholding surgery based on the BMI is not justified.

This was a safety study where the hypothesis was that the newer-design CPCS femoral stem would demonstrate similar early clinical results and micromovement to the well-established Exeter stem. Both are collarless, tapered, polished cemented stems, the only difference being a slight lateral to medial taper with the CPCS stem. A total of 34 patients were enrolled in a single-blinded randomised controlled trial in which 17 patients received a dedicated radiostereometric CPCS stem and 17 a radiostereometric Exeter stem. No difference was found in any of the outcome measures pre-operatively or post-operatively between groups. At two years, the mean subsidence for the CPCS stem was nearly half that seen for the Exeter stem (0.77 mm (−0.943 to 1.77) and 1.25 mm (0.719 to 1.625), respectively; p = 0.032). In contrast, the mean internal rotation of the CPCS stem was approximately twice that of the Exeter (1.61° (−1.07° to 4.33°) and 0.59° (0.97° to 1.64°), respectively; p = 0.048). Other migration patterns were not significantly different between the stems. The subtle differences in designs may explain the different patterns of migration.

Comparable migration with the Exeter stem suggests that the CPCS design will perform well in the long term.

Purpose: The increasing trend of morbidly obese patients (BMI 40+) requiring joint replacement is becoming a growing concern in Total Hip Replacement (THR) surgery. The purpose of this study was to investigate the influence that BMI may have on implant longevity and clinical outcome using prospectively collected patient data.

Method: A consecutive cohort of 2864 THR’s in 2488 patients with osteoarthritis and a minimum 2 years follow-up were evaluated. Patients were divided into appropriate BMI categories; Normal and Underweight (BMI< 25, n=650), Overweight (BMI 25–29.9, n=1069), Obese (BMI 30–39.9, n=981), and Morbidly Obese (BMI 40+, n=164). Pre-operative, latest, and change in clinical outcome scores (HSS, SF12, WOMAC) were analyzed using ANOVA and Kaplan-Meier (K-M) survivorship was determined. Categorical variables such as gender and survival status were analyzed using chi-squared.

Results: Morbidly Obese patients requiring THR’s were significantly younger than all other BMI groups by 5.4±0.83 years (p< 0.0001). Gender was also significant to BMI grouping with more females being Morbidly Obese and Normal or Underweight (p< 0.0001). All pre-operative and latest HHS and WOMAC domain scores were lower for the Morbidly Obese, significantly in all preoperative score domains and latest HHS Function (p< 0.05). The change in clinical scores from pre-operative to latest was greatest in all domains for the Morbidly Obese group. K-M cumulative survival with implant revision as the endpoint at 10 years was not different between the BMI groups. Revision rates for infection for the Morbidly Obese, Obese, Overweight, and Normal were 1.3%, 0.65%, 0.3% and 0.69% respectively. Overall Revision rates for the Morbidly Obese, Obese, Overweight, and Normal were 6.7%, 5.4%, 6.9% and 5.7% respectively and were not found to be significant (p=0.496).

Conclusion: The Morbidly Obese cohort undergoing THR had significantly lower preoperative and lower postoperative clinical outcome scores than all other BMI groups but demonstrated the most significant improvement. No difference was found in the K-M survivorship although revisions and revisions for infection were not equal between the groups

Purpose: Gender specific total knee replacement design has been a recently debated controversial topic. The purpose of this study was to investigate the survivor-ship and clinical outcomes of a large primary total knee arthroplasty cohort, specifically assessing any differences between gender groups.

Method: A consecutive cohort of 3817 patients with osteoarthritis, having undergone 5289 primary total knee replacements (3100-female, 2179-male) with a minimum of 2 years follow-up were evaluated. All surgeries were performed at the same institution by one of four surgeons. Pre-operative scores, latest scores, and change in clinical outcome scores (KSCRS, SF12, WOMAC) were compared and tested for significance using the students t-test. Kaplan Meier (K-M) survivor-ship was determined and tested for significance and categorical variables were compared using chi-squared.

Results: Men were significantly taller and heavier than women, while women had significantly higher BMI’s (p< 0.0001). While men had higher raw scores preoperatively, women demonstrated statistically greater improvement (p< 0.019) in all WOMAC domains including pain (29.87 vs. 27.30), joint stiffness (26.78 vs. 24.26), function (27.21 vs. 23.09) and total scores (28.34 vs. 25.09) There were no gender differences in improvements of the SF12 scores. Men demonstrated statistically greater improvement (p< 0.0001) in Knee Society function (22.10 vs. 18.63) and total scores (70.01 vs. 65.42), but not the Knee Society knee score (47.83 vs. 46.64, p=0.084). K-M cumulative survivorship at 10 years was 87.4±.01 for females and 82.9±.014 for males. K-M survivorship distribution was found to be significantly different between gender groups (p< 0.013, Mantel-Cox, Breslow, Tarone-Ware). Revision rates were 10.2% for males and 8.3% for females which was found to be significant by crosstabs with chi-squared (p=0.006).

Conclusion: In this cohort of patients undergoing total knee replacements, women demonstrated statistically greater implant survivorship, statistically greater improvement in WOMAC scores and less improvement in KSCR scores, leading one to question the hypothesis of an inferior clinical outcome in total knee arthroplasty that is gender based.